3K3A-APC Protein ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05039268 (ClinicalTrials.gov)	November 25, 2021	23/8/2021	3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)	A Phase 2 Open Label Trial of 3K3A-APC in Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: 3K3A-APC Protein	Macquarie University, Australia	ZZ Biotech, LLC	Recruiting	18 Years	75 Years	All	16	Phase 2	Australia